title: Effects of hyperosmolar glucose, prostaglandin-F2 alpha and 15-methyl-prostaglandin-F2 alpha on human placental cells in vitro.
abstract: The objective of this study was to assess the ability of certain drugs, used for local injection therapy of ectopic pregnancy, to suppress the activities of cultured human placental cells. Placental cells from legal first trimester abortions were prepared by collagenase treatment and density gradient centrifugation. The cells were exposed to hyperosmolar glucose (500 mg/ml), 15-methyl-prostaglandin-F2 alpha (15-m-PGF2 alpha; 10(-7) to 10(-3) mol/l) and prostaglandin-F2 alpha (PGF2 alpha; 10(-5) to 5 x 10(-3) mol/l) for 30 min on days 2-4 after seeding. The effects on the secretion of human chorionic gonadotrophin (HCG) and progesterone, as well as on the protein content per culture well, were measured. Hyperosmolar glucose was the most effective drug and caused a marked decrease of the protein content in the culture wells and a reduction of progesterone secretion. Of the two prostaglandins, only 15-m-PGF2 alpha affected the viability of the cells and reduced the protein content of the wells. The clinical effectiveness of the two groups of drugs seems to be similar but certain in-vitro effects are different. Thus in vivo they may act on different target tissues. Against this background, the combination of hyperosmolar glucose and prostaglandins might be an interesting approach for local injection therapy for tubal pregnancy.
authors.affiliation: Department of Obstetrics and Gynecology, University of Göteborg, Sahlgrenska Hospital, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Bengtsson
authors.forename: A
authors.initials: A
authors.lastname: Wallin
authors.forename: P
authors.initials: P
authors.lastname: Sjöblom
authors.forename: B
authors.initials: B
authors.lastname: Lindblom
mesh_terms: D002260:Carboprost / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D015237:Dinoprost / Q000494:pharmacology*; D005260:Female; D005455:Fluorescent Antibody Technique; D005947:Glucose / Q000494:pharmacology*; D006728:Hormones / Q000378:metabolism; D006801:Humans; D009994:Osmolar Concentration; D010920:Placenta / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism
chemical_list: D006728:Hormones; D002260:Carboprost; D015237:Dinoprost; D005947:Glucose